ProblemHuman implantation is a limiting factor for the success of natural and IVF reproduction since about 60% of pregnancy losses occur in the peri‐implantation period. The in vitro modeling of human implantation challenges the researchers in accurate recreation of the complex in vivo differentiation and function of human blastocyst in the peri‐implantation period. In previous studies, we constructed Sw71‐spheroid models, which like human blastocyst undergo compactization, attaches to the endometrial epithelium, invade, and migrate. The aim of this study was to validate the trophoblast Sw71‐spheroid model with primary trophoblast cells, derived from healthy women in early pregnancy.Method of StudyWe performed a direct comparison of Sw71‐spheroid model with placenta‐derived primary trophoblasts regarding their hybrid phenotype and HLA status, as well as the ability to generate spheroids able to migrate and invade. From the primary trophoblast cells, isolated by mild enzymatic treatment and Percoll gradient separation, were generated long‐lived clones, which phenotype was assessed by FACS and immunocytochemistry.ResultsOur results showed that cultured primary trophoblasts have the EVT phenotype (Vim+/CK7+/HLA‐C+/HLA‐G+), like Sw71 cells. In both 3D culture settings, we obtained stable, round‐shaped, multilayered spheroids. Although constructed from the same number of cells, the primary trophoblast spheroids were smaller. The primary trophoblast spheroids migrate successfully, and in term of invasion are equally potent but less stable as compared to Sw71 spheroids.ConclusionsThe Sw71 cell line and cultured native trophoblast cells are interchangeable regarding their EVT phenotype (HLA‐C+/HLA‐G+/Vim+/CK7+). The blastocyst‐like spheroids sourced by both types of cells differentiate in the same time frame and function similarly. We strongly advise the use of Sw71 spheroids as blastocyst surrogate for observation on trophectoderm differentiation and function during early human implantation.